Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania

Completed · Phase 4

Conditions studied: Trachoma

In brief

After single, yearly, mass treatment of communities with azithromycin for active trachoma, what is the added effectiveness for reduction of trachoma and ocular C. trachomatis infection at one, two, and three years, relative to the added costs, of community-based surveillance and treatment of cases of severe trachoma (TI) semi-annually or every 4 months?

Key facts

Study ID

NCT00347607

Run by

Johns Hopkins University

People needed

2700

Starts

2002-04-01

Expected to finish

2005-11-01

Last updated by the study team

2011-10-28

Who can join

Age: 1 and older, up to 7. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• villages not in the Tanzania National Trachoma control Program in Kongwa, Tanzania
• villages with population size less than 5,000
• sentinel children: ages 1 year to 7 years

You may not qualify if…

• Village leadership refuses to allow village participation
• sentinel children: previous history of treatment with azithromycin
• sentinel children: another family member (child)already enrolled in study

Where it is running

• Johns Hopkins university — Baltimore, Maryland, United States
• Kongwa Trachoma Project — Kongwa, Dodoma, Tanzania

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.